Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Sampling Modification Effects in the Subgingival Microbiome Profile of Healthy Children.

Santigli E, Trajanoski S, Eberhard K, Klug B.

Front Microbiol. 2017 Jan 18;7:2142. doi: 10.3389/fmicb.2016.02142. eCollection 2016.

2.

Performance of Bedside Lung Ultrasound by a Pediatric Resident: A Useful Diagnostic Tool in Children With Suspected Pneumonia.

Zhan C, Grundtvig N, Klug BH.

Pediatr Emerg Care. 2016 Oct 4. [Epub ahead of print]

PMID:
27749801
3.

Modulators of the extracellular matrix and risk of anterior cruciate ligament ruptures.

Rahim M, Mannion S, Klug B, Hobbs H, van der Merwe W, Posthumus M, Collins M, September AV.

J Sci Med Sport. 2017 Feb;20(2):152-158. doi: 10.1016/j.jsams.2016.07.003. Epub 2016 Sep 28.

PMID:
27720349
4.

From Mouth to Model: Combining in vivo and in vitro Oral Biofilm Growth.

Klug B, Santigli E, Westendorf C, Tangl S, Wimmer G, Grube M.

Front Microbiol. 2016 Sep 21;7:1448. eCollection 2016.

5.

Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.

Clarke DK, Hendry RM, Singh V, Rose JK, Seligman SJ, Klug B, Kochhar S, Mac LM, Carbery B, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group..

Vaccine. 2016 Dec 12;34(51):6597-6609. doi: 10.1016/j.vaccine.2016.06.071. Epub 2016 Jul 6.

PMID:
27395563
6.

Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis.

Klug B, Robertson JS, Condit RC, Seligman SJ, Laderoute MP, Sheets R, Williamson AL, Gurwith M, Kochhar S, Chapman L, Carbery B, Mac LM, Chen RT; Brighton Collaboration Viral Vaccine Vector Safety Working Group. Electronic address: brightoncollaborationv3swg@gmail.com..

Vaccine. 2016 Dec 12;34(51):6617-6625. doi: 10.1016/j.vaccine.2016.02.015. Epub 2016 Jun 15.

7.

Accuracy of commercial kits and published primer pairs for the detection of periodontopathogens.

Santigli E, Leitner E, Wimmer G, Kessler HH, Feierl G, Grube M, Eberhard K, Klug B.

Clin Oral Investig. 2016 Dec;20(9):2515-2528. Epub 2016 Mar 29.

8.

Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk/benefit assessment.

Monath TP, Seligman SJ, Robertson JS, Guy B, Hayes EB, Condit RC, Excler JL, Mac LM, Carbery B, Chen RT; Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG)..

Vaccine. 2015 Jan 1;33(1):62-72. doi: 10.1016/j.vaccine.2014.10.004. Epub 2014 Oct 27. Review.

9.

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).

Chen RT, Carbery B, Mac L, Berns KI, Chapman L, Condit RC, Excler JL, Gurwith M, Hendry M, Khan AS, Khuri-Bulos N, Klug B, Robertson JS, Seligman SJ, Sheets R, Williamson AL; V3SWG..

Vaccine. 2015 Jan 1;33(1):73-5. doi: 10.1016/j.vaccine.2014.09.035. Epub 2014 Oct 8.

10.

Molecular support for the recognition of the Mycoblastus fucatus group as the new genus Violella (Tephromelataceae, Lecanorales).

Spribille T, Goffinet B, Klug B, Muggia L, Obermayer W, Mayrhofer H.

Lichenologist. 2011 Sep;43(5):445-466.

11.

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Gershman MD, Staples JE, Bentsi-Enchill AD, Breugelmans JG, Brito GS, Camacho LA, Cottin P, Domingo C, Durbin A, Gascon J, Guenaneche F, Hayes EB, Jelenik Z, Khromava A, Martins Rde M, Wilson MM, Massy N, Nasidi A, Niedrig M, Sherwat A, Tsai T, Vilella A, Wilson ME, Kohl KS; Brighton Collaboration Viscerotropic Disease Working Group..

Vaccine. 2012 Jul 13;30(33):5038-58. doi: 10.1016/j.vaccine.2012.04.067. Epub 2012 May 4. No abstract available.

12.

Regulatory structures for gene therapy medicinal products in the European Union.

Klug B, Celis P, Carr M, Reinhardt J.

Methods Enzymol. 2012;507:337-54. doi: 10.1016/B978-0-12-386509-0.00017-X.

PMID:
22365782
13.

Trafficking in persons and victim health in Australia.

Schloenhardt A, Klug B.

J Law Med. 2011 Dec;19(2):397-414.

PMID:
22320010
14.

Oral biofilm analysis of palatal expanders by fluorescence in-situ hybridization and confocal laser scanning microscopy.

Klug B, Rodler C, Koller M, Wimmer G, Kessler HH, Grube M, Santigli E.

J Vis Exp. 2011 Oct 20;(56). pii: 2967. doi: 10.3791/2967.

15.

Aluminium localization in root tips of the aluminium-accumulating plant species buckwheat (Fagopyrum esculentum Moench).

Klug B, Specht A, Horst WJ.

J Exp Bot. 2011 Nov;62(15):5453-62. doi: 10.1093/jxb/err222. Epub 2011 Aug 9.

16.

A phylogenetic analysis of the boreal lichen Mycoblastus sanguinarius (Mycoblastaceae, lichenized Ascomycota) reveals cryptic clades correlated with fatty acid profiles.

Spribille T, Klug B, Mayrhofer H.

Mol Phylogenet Evol. 2011 Jun;59(3):603-14. doi: 10.1016/j.ympev.2011.03.021. Epub 2011 Mar 30.

17.
18.

Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M; Brighton Collaboration GBS Working Group..

Vaccine. 2011 Jan 10;29(3):599-612. doi: 10.1016/j.vaccine.2010.06.003. Epub 2010 Jun 18. Review. No abstract available.

PMID:
20600491
19.
20.

Spatial characteristics of aluminum uptake and translocation in roots of buckwheat (Fagopyrum esculentum).

Klug B, Horst WJ.

Physiol Plant. 2010 Jun 1;139(2):181-91. doi: 10.1111/j.1399-3054.2010.01355.x. Epub 2010 Jan 19.

PMID:
20088907

Supplemental Content

Loading ...
Support Center